HUP9701618A2 - Tramadolt és valamely kálciumcsatorna antagonistát tartalmazó gyógyászati készítmény - Google Patents

Tramadolt és valamely kálciumcsatorna antagonistát tartalmazó gyógyászati készítmény

Info

Publication number
HUP9701618A2
HUP9701618A2 HU9701618A HUP9701618A HUP9701618A2 HU P9701618 A2 HUP9701618 A2 HU P9701618A2 HU 9701618 A HU9701618 A HU 9701618A HU P9701618 A HUP9701618 A HU P9701618A HU P9701618 A2 HUP9701618 A2 HU P9701618A2
Authority
HU
Hungary
Prior art keywords
calcium
canal
antagonist
pharmaceutical composition
composition containing
Prior art date
Application number
HU9701618A
Other languages
English (en)
Inventor
Wolfgang Reimann
Original Assignee
Grünenthal GmbH.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH. filed Critical Grünenthal GmbH.
Publication of HUP9701618A2 publication Critical patent/HUP9701618A2/hu
Publication of HUP9701618A3 publication Critical patent/HUP9701618A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány szerinti kőmbinációs készítmény tramadőlt és valamelykalciűmcsatőrna-antagőnistát tartalmaz és különösen fájdalmakkezelésére alkalmas. Kalciűmcsatőrna-antagőnistaként példáűl minődipint, diltiazemet vagyverapramilt tartalmazhat a készítmény. ŕ
HU9701618A 1996-10-09 1997-10-08 Pharmaceutical composition containing tramadol and a calcium-canal-antagonist HUP9701618A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19641576A DE19641576C1 (de) 1996-10-09 1996-10-09 Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten

Publications (2)

Publication Number Publication Date
HUP9701618A2 true HUP9701618A2 (hu) 1999-01-28
HUP9701618A3 HUP9701618A3 (en) 1999-10-28

Family

ID=7808249

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701618A HUP9701618A3 (en) 1996-10-09 1997-10-08 Pharmaceutical composition containing tramadol and a calcium-canal-antagonist

Country Status (13)

Country Link
US (1) US5929122A (hu)
EP (1) EP0835656B1 (hu)
JP (1) JPH10147520A (hu)
AT (1) ATE209485T1 (hu)
AU (1) AU726341B2 (hu)
CA (1) CA2217846A1 (hu)
DE (2) DE19641576C1 (hu)
DK (1) DK0835656T3 (hu)
ES (1) ES2168562T3 (hu)
HK (1) HK1009400A1 (hu)
HU (1) HUP9701618A3 (hu)
PT (1) PT835656E (hu)
SI (1) SI0835656T1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1289071C (zh) 2001-03-16 2006-12-13 Dmi生物科学公司 曲马朵物质在制备用于延缓男性射精的药物中的用途
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
DE10227511A1 (de) * 2002-06-19 2004-01-08 Max-Delbrück-Centrum für Molekulare Medizin Mittel zur medikamentösen Behandlung von akuten und chronischen Schmerzen
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
WO2006105670A1 (en) * 2005-04-08 2006-10-12 Neuromed Pharmaceuticals Ltd. Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
PL387984A1 (pl) * 2009-05-07 2010-11-08 Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW14392A1 (en) * 1991-09-06 1994-05-11 Mcneilab Inc "Compositions comprising a tramadol material and any of codeine, oxycodone or bydrocodone and their use"
ATE169498T1 (de) * 1991-09-06 1998-08-15 Mcneilab Inc Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug

Also Published As

Publication number Publication date
EP0835656B1 (de) 2001-11-28
AU3998497A (en) 1998-04-23
PT835656E (pt) 2002-05-31
HUP9701618A3 (en) 1999-10-28
DE19641576C1 (de) 1998-05-07
EP0835656A1 (de) 1998-04-15
DE59705525D1 (de) 2002-01-10
JPH10147520A (ja) 1998-06-02
US5929122A (en) 1999-07-27
ES2168562T3 (es) 2002-06-16
HK1009400A1 (en) 1999-06-04
ATE209485T1 (de) 2001-12-15
CA2217846A1 (en) 1998-04-09
SI0835656T1 (en) 2002-08-31
AU726341B2 (en) 2000-11-02
MX9707719A (es) 1998-06-30
DK0835656T3 (da) 2002-02-11

Similar Documents

Publication Publication Date Title
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
YU28199A (sh) Novi oblik jedinjenja
HUP9801240A2 (en) Oral compositions
DE69905170D1 (en) Thiazolopyrimidinderivate
GT199700009AA (es) Terapia combinada para la osteoporosis
HUP0100950A3 (en) Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
EP0911321A3 (en) Compounds for the treatment of osteoporosis
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
AP9801269A0 (en) Prostaglandin agonists.
SI1028950T1 (en) 7-substituted quinazolin-2,4-diones useful as antibacterial agents
BG102818A (en) D-manitol and method for its preparation
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
YU13301A (sh) Muskarinski agonisti i antagonisti
BG104916A (en) Calcilytic compounds
HUP9701618A2 (hu) Tramadolt és valamely kálciumcsatorna antagonistát tartalmazó gyógyászati készítmény
AU623805B2 (en) New use of anti-progestomimetic compounds
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
BG102667A (en) Diosgenine-containing composition
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
ZA966953B (en) Pharmaceutical composition.
UA48962C2 (uk) Біциклічні антагоністи тахікінінів, фармацевтична композиція та спосіб лікування
BR9808447A (pt) Composto, uso do mesmo, processo para sua preparação, e, composição farmacêutica